September 19, 2025

Get In Touch

Ayush Ministry Announces Initiation Of Phase 3 Trial For Rheumatoid Arthritis

Ayurveda Clinical Trial

Ayurveda Clinical Trial for Rheumatoid Arthritis

New Delhi: The Ayush Ministry has initiated the world's first multicentre phase-3 clinical trial to examine the efficacy of Ayurveda in the treatment of rheumatoid arthritis, according to an official statement.

The clinical trial will be conducted following the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use Good Clinical Practice guidelines, it stated.

Also Read: Govt of India accorded great importance to ISM and Unani: Sonowal

It will be closely monitored by Dr. Daniel Erick Furst, a renowned rheumatologist at the University of California, the statement mentioned.

This project is one of the first multi-center phase-3 double-blind double-dummy clinical trials on the efficacy of Ayurveda in the management of rheumatoid arthritis, it claimed.

The trial will be conducted by AVP Research Foundation, affiliated with the Arya Vaidya Pharmacy (Coimbatore) Ltd and the Central Council for Research in Ayurveda, an agency under the Ayush Ministry.

Dr. Somit Kumar, Director of AVP Research Foundation and co-investigator of this study, said, "AMRA, a double-blind double-dummy randomized clinical trial, is taking Ayurveda research in rheumatology to a global stage."

Dr. M N Shubhashree, Research Officer, Central Ayurveda Research Institute for Metabolic Disorders, Bengaluru, said the study is expected to begin in May and be completed in the next two years.

The sample size has increased almost 5 times, from 48 patients to 240, Dr. Shubhashree said.

"Clinical trials will be conducted at:

  • AVP Research Foundation in Coimbatore
  • Central Ayurveda Research Institute for Metabolic Disorders in Bengaluru
  • Raja Ramdeo Anandilala Central Ayurveda Research Institute for Cancer in Mumbai

Earlier, the National Institutes of Health in the USA funded a clinical trial at the University of Washington in Seattle to compare the efficacy and safety of classical Ayurvedic treatment to standard Allopathic treatment for rheumatoid arthritis.

The findings of this study have been published in prestigious journals such as the Annals of Rheumatic Diseases and the Journal of Clinical Rheumatology, the statement said.

Also Read: Mizoram: Shri Sarbananda Sonowal announces major healthcare boost, lays foundation stones for Six Ayush Hospitals

Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our Terms of Use, Privacy Policy, and Advertisement Policy.
For further details, please review our Full Disclaimer.

0 Comments

Post a comment

Please login to post a comment.

No comments yet. Be the first to comment!